Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-009890

CFO and Treasurer sold 1,448 shares at an average $74.68 ($108,135)

  • CFO and Treasurer acquired 4,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2021-02-07 Option exercise +4,250 14,427 D
Krognes Steve E. CFO and Treasurer 2021-02-09 Sale −1,022 $74.38 $76,018 13,405 D
Krognes Steve E. CFO and Treasurer 2021-02-09 Sale −426 $75.39 $32,116 12,979 D
Derivatives
Krognes Steve E. CFO and Treasurer 2021-02-07 Option exercise · Restricted Stock Units −4,250 8,500 D
Open-market sales · 1,448 sh · avg $74.68 · $108,135
Loading xslF345X03/doc4.xml…